Unternehmen ProMIS Neurosciences, Inc. Toronto S.E.
Aktien
A3DM9Q
CA74346M4065
PMN
Biotechnologie
Kurzporträt
Mitarbeiterzahl: 7
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Neil Warma
CEO | Chief Executive Officer | 61 | 13.05.21 |
Neil Cashman
FOU | Founder | 72 | 23.01.04 |
Eugene Williams
CHM | Chairman | 64 | 29.06.15 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 22.03.17 |
Gavin Malenfant
COO | Chief Operating Officer | 61 | 22.10.21 |
Larry Altstiel
CTO | Chief Tech/Sci/R&D Officer | 74 | 19.04.22 |
Suzanne Messere
IRC | Investor Relations Contact | - | - |
Dennis Chen
PRN | Corporate Officer/Principal | - | - |
David Wishart
PRN | Corporate Officer/Principal | - | 27.05.21 |
Ernest D. Bush
PRN | Corporate Officer/Principal | - | 03.04.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
William W. Wyman
BRD | Director/Board Member | 86 | 08.03.14 |
Neil Cashman
FOU | Founder | 72 | 23.01.04 |
Neil Warma
CEO | Chief Executive Officer | 61 | 13.05.21 |
Eugene Williams
CHM | Chairman | 64 | 29.06.15 |
Patrick Kirwin
BRD | Director/Board Member | - | 29.06.15 |
Director/Board Member | 41 | 01.09.21 | |
Director/Board Member | 65 | 22.09.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 18 961 116 | 14 344 157 ( 75,65 %) | 0 | 75,65 % |
Unternehmenskontakt
ProMIS Neurosciences, Inc.
1920 Yonge Street Suite 200
M4S 3E2, Toronto
+416 847 6898
http://www.promisneurosciences.comSektor
% 1. Jan. | Kap. | |
---|---|---|
-0.49% | 105 Mrd. | |
+3.31% | 97.5 Mrd. | |
+3.00% | 22.19 Mrd. | |
-16.16% | 21.33 Mrd. | |
-7.29% | 18.68 Mrd. | |
-41.41% | 16.6 Mrd. | |
-22.87% | 14.52 Mrd. | |
+6.32% | 14.09 Mrd. | |
+21.46% | 10.99 Mrd. |